tirzepatide ban update 🚨 Important on Compounded 🚨, As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable Compounding pharmacies can resume making

Consider the needed dietary and lifestyle changes that support tirzepatides potential effectiveness

Summary: In Phase 2 clinical trials, retatrutide was typically initiated at 2 mg once weekly via subcutaneous injection, with gradual dose escalation over several months under close medical supervision

A.CruzM

Public Relations and Transparency Efforts: To manage public perception, Novo Nordisk has engaged in transparent communication about ongoing research, updates to drug information, and responses to regulatory inquiries

Your nervous system has a volume dial for sensory input

Another advantage of squalane is that it is pretty much compatible with all skin types and skin conditions